Race against superbug: new drug combo enters final testing for deadly hospital pneumonia
NCT ID NCT07326540
Summary
This study is testing a new antibiotic combination (BV100 plus polymyxin B) against a standard treatment for a severe type of pneumonia caught in hospitals. It focuses on infections caused by a bacteria that resists most antibiotics, making them very hard to treat. The main goal is to see if the new combination is more effective at saving lives 28 days after treatment starts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOSPITAL ACQUIRED BACTERIAL PNEUMONIA (HABP) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.